(Total Views: 381)
Posted On: 02/24/2019 11:35:03 AM
Post# of 33190
Company 5
DiaMedica Therapeutics Inc.
(NASDAQ
MAC) (TSX‑V MA)
Market Cap: $42M
Revenue: "we are an early stage company with no approved products and no revenue"
Announced pricing, approval and uplisted all on the same day.
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
https://globenewswire.com/news-release/2018/1...STING.html
DiaMedica Therapeutics Inc.
(NASDAQ
MAC) (TSX‑V MA) Market Cap: $42M
Revenue: "we are an early stage company with no approved products and no revenue"
Announced pricing, approval and uplisted all on the same day.
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
https://globenewswire.com/news-release/2018/1...STING.html
(6)
(0)
